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Summary . Thc major pmhological abnormalilic~ of HIV cn-
ccphalopalhy lITe infiltrates of m:lcrophagcs. multinuc1eatcd 
giant cells . mieroglial nodulcs and dcmyclination . Elevil!ed 
myelin basic pralein (MBP) levels in {he cerebrospinal fluid 
(CS F) providc a marker for cenual nervous system demyeli· 
nation . The purpose of this study was 10 invesligale the pos-
sible role of CSF MBP as ,I uscful and early markcr for HI V 
cnccphalopathy. The CS F of 40 consccutive paticms with HIV 
infcction of various dinieal stages was invcstigated. induding 
13 patienls with dinical signs of 1"lI V eneephalopathy. CSF 
MB P was clcvatcd in 2 paticms (5 .0 and 5.3nglml). bolh of 
whorn hOld moderate 10 severe HIV encephalopathy. Thc 
course ofl he disease was rapid in both patients. In the remain-
ing 38 paticms. CSF MBP levels werc marginally elcvaled 
(11 = 12) or normal (11 "" 26)_ Our results suggest that CSF 
MBP is not iI sensitive marker for the diagnosis and evaluation 
of HIV encephalopathy . but may be an indieator of prognosis 
for Ihe course of the discase. Therc wcre only fcw findings of 
clcvatcd CSF MBP levels in patiems with HI V encephala-
path y in the CUTrent study . and Ihis may be because the dis-
order progres.<;ed slowly in most patients. It is possible thaI 
CSF MB P levels in HI V cneephalopalhy mny only be elevated 
with aeute cl inieal deterioration bUl are normal in slowly pro-
gressive forms of dernyelin ation. as seen in multiple sclerosis. 
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Introduetion 
Neurological disorders ha\'e been rcp<lftcd in approximatcl~' 
40% of adult AIDS patienls \11. 221. Howcver. up to 70%-
80% of adult AIDS paticms have been shown 10 have neuro-
palhologieallibnormalit il!s in autopsy·based survcys (14. 19). 
Thc most freque nt and most importam cause of neurological 
morbidity in I-II V-infected paticnls is HIV eneephalopalhy 
PJ. Therc is incrcasing evidencc that this disordcr. which has 
also been rcfcITcd 10 as subaeule enccphali tis [17 . 19J or A1DS 
dementia complex (1 5. 16.20). is eaused by dircet J-II V brain 
in fcction. The white matter and subcortical struetures of the 
cerebral hemisphcrcs are most severely involved wilh relative 
sparil1!1 of the cortex [8, 14 , 18. 19). The major pathologieal ab-
normali ties are infiltrates of maerophagcs and multinueleated 
siant eells and microglial nodules. Involvement of the white 
matter appcars either as diffuse leueoencephalopathy with 
scverc loss of myelin or as small paravaseular foei of dcmyc1i-
nalion [5. 8. 10 . 16) . De la Monle et aL [51 reponcd demyeli-
nation in 44% of autopsy eascs with HIV cncephalopathy . 
Elevatcd myclin basic protein (MBP) levels within Ihe ce· 
rebrospinal fluid (CSF) provide a marker for central nervous 
system demyclinalion. as has been shown in patients with re-
lapsing-remitling multiple sclerosis (3 , 13.24). The purpose of 
the presenl study was 10 investigate if CSF MBP has a rolc as 
a uscful and earl y marker for HIV cncephalopathy. We inves-
ligated CSF sampies of 40 conseeuti\"e patiems with HI V in-
feelion of various clinical stages. including 13 wilh clinical 
signs of HIV eneephalopalhy . 
Paticnts and mcthods 
Seven of the HIV-poSitive persons were c!inieaJ1y healthy 
(stage WR I). 22 suffered from the Iymphadcnopal hy syn-
drome or the A IDS-related eomplex (WR 2-5) and 11 had 
full-blown AIDS (WR 6). Clinically manifest HI V eneephalo-
pathy was diagnosed in 13 patients. Symptoms of mental de-
terioration (tl = 11) and /or pomomesenecphalic o r cerebellar 
dysfunelion (n - 4) wcrc used as diagnostie eri teria (Table I) . 
Opportunistic conditions. including bath infections and nco-
plasms. werc not evident in these 13 patients wit h HIV en-
ccphalopa{hy. 
CSF and scrum sampIes werc eolleeted from 40 HI V-posi-
live patients. Oligoclonal IgG bands were detected by iso-
cleetrie focusing . Thc sampies were coneentrated and run on 
a polyacrylamide gel at a pH gradient of 3-9 (Phast-System; 
Pharmacia. Uppsata. Swcden). The gels wcre staincd with 
Coomassie blue. The ratio CSF albumin/serum albumin was 
uscd as an indieator of blood-CSF-barrier permeabilit}·. A 
commereial EUSA was uscd \0 determine IgO antibody lilres 
to I-II V. A CSF/serum quotient of IgG·related HIVantibodies 
above 1.5 was considered to indicate intrathecal produetion of 
HIV antibodies [121 . MB P in CSF W3S determined using a 
com mcrcial. competi live radioimmunoassay (Biodma; Milan . 
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haly). Fifty microlitrcs of a histone solution (2.5 nglml) was 
added 10 5001-\1 fresh CSF sampIe to prevent adhesion. The 
sampIes were Slored al - 18°C until they werc analysed. The 
reference range for MBP in CSF was defined as follows: up 10 
3.4 nglml, normal; 3.4-4.6nglml , marginal; and above 4.6ngl 
ml, elevated. 
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myelopathy 
CSF abnormalit ies wcre detected in 32 patients (80%). 
Oligodonal IgG bands werc found in the CSF of 29 patients 
(73%); 18 of 24 patients wilh oligoclonal IgG bands in the 
CSF had evidencc of intrathecal HlV antibody production. 
Lymphocytic pleocytosis ranging from 5 10 J46 ce llsl~1 was 
present in 17 patients and an c\cvated ratio of CSF albuminl 
se rum albumin (> 7.5) in 8 pat ients. 
CSF MBP was elevated in two paticnts (5.0 and 5.3 nglm1). 
bot h suffcring from full-blow n AID S. Dne of these patiems 
presented wit h severe dementia and a his to ry of oesophagitis. 
T hc othcr patient had a history of PIlt!umocyslis caritlii 
pncu monia and presen led with moderme dement ia und seve re 
myelopathy which could not be attributed to any condition 
o lher than H IV infection. Neurological symptoms had pro-
gressed rapidly over a few mo nths in both patients. In the re-
maining 38 patients. CSF MBP levels were marginally ele-
vated (11 = 12) or normal (11 = 26). Thcre was no significant 
corrclat ion bctwecn elevated (i ncluding margina1ly elevated) 
CSF MBP levels and in lrathecal HI V ant ibody production. 
o ligoclonal lgG bands, or Iymphocytic pleocytosis (chi-square 
test. 1' > 0.05). 
Discussion 
Elevated levels of CSF MB P secondary 10 aeute myelin break-
down are present in rnany patiel1ts wi th act ive disease of the 
ncrvous system. e.g. mul tiple sc\erosis. tranverse myelitis. 
central pantine myelinolysis [3. 25 j. In thc current slUdy cle-
vi.lled MBP CSF levels were detecled in only 2 patients. both 
or whom presented with modcrate to se\'cre H IV encephalo-
pat hy. In the OIher II patients with HI V cncephalopat hy as 
weil as in 27 HJ V pat ienls without clinically apparent HI V en-
cephalopmhy. only margin ally elevated or normal MBP levels 
were fou nd . Therc was 110 sign ifica nl eorrdat ion betwcen CSF 
MBP levels and intra lhecal HI Va ntibody produclion. Our re-
sulls suggest that CSF MBP is not a sensitive marke r fo r the 
diagnosis and evaluat ion of H IV encephalopal hy. 
Thc rapidity or dcmyeiination seems LO influence MBP 
levels in the CSF. 3S is known from studies in multiple sclero· 
sis [2. 4, 131. In mult iple selcrosis elevated MBP was usually 
dctected in the CS F of pat ients during acute exace rbations of 
Ihe disease. MB P was not deteeted in the CSF or any pat ient 
with a slowly progressive form of mul tiple sclerosis. It was 
speculaled that in slowly progressive demyelinat ion CSF MBP 
might bc degraded by macrophages or proteinases or inaeti-
vatcd by ant ibodies. thus prevenling elevation of MßP [I. 6. 
13.21. 23]. The rare fin ditlg of e levated CSF MBP levels in 
patients with J-IJ V encephalopathy in the current st udy may be 
explai ned by the fact thm thc disorde r is more often chroni-
cally progressive Ihan subaeute in its evolution [20J. It must bc 
strcssed tha t in the current study Ihe c\inical course of HI V en-
eephalopalhy in the 2 pa tients with e1cvated CSF MBP levels 
differed from that of the other patients wit h HIV encephalo-
palh}' in that both suffeTcd rapidly progressive dementia. 
Since CSF MBP is clevated in acute exacerbations o r multiple 
sclerosis as we1l as in rapid progressive cases of HI V eneeph-
alopm hy. we think Iha! an elevated CSF MBP level may be a 
prognos tie marker for the course of HI V cncephalopathy . 
Previous st udies in paticnts with olher neurological dis-
eases havc shown that CSF MB P is not a specific marker. 
Dther neurological disorders afrecting the CNS in I-II V-in-
feeted pmients. such :\s progressive mult ifocal leucocnce-
phalopmhy [25 ] or herpes simplex encephalit is [9j, mayaiso 
cause e1evated CSF MBP levels. Furthermore. combinations 
or Hl V encephaloparhy and oppoflunis tic infections may 
occur. whieh complicate Ihe interpretation of devated CSF 
MBP levels. 
We conclude that CSF MB P is not a sensitive marker for 
H IV encephalopat hy. Thc significa nce or normal and margi-
nally clevatcd CSF MBP levels with respcci to demyeli nat ion 
is unknown. Elcvatcd CSF MBP Icvels may indicatc a rapid!y 
progressive course of H IV encephalopathy provided that 
ot ller CNS disease is not prcscnt. 
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